These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension. Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530 [TBL] [Abstract][Full Text] [Related]
6. Use of clonidine and propranolol as monotherapy in borderline hypertension. Cottier C; Julius S Chest; 1983 Feb; 83(2 Suppl):422-5. PubMed ID: 6337032 [TBL] [Abstract][Full Text] [Related]
7. Rebound hypertension after discontinuation of transdermal clonidine. Schmidt GR; Schuna AA Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898 [No Abstract] [Full Text] [Related]
8. Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Geyskes GG; Boer P; Dorhout Mees EJ Br J Clin Pharmacol; 1979 Jan; 7(1):55-62. PubMed ID: 760743 [TBL] [Abstract][Full Text] [Related]
12. Regimen for the control of blood pressure and symptoms during clonidine withdrawal. Campbell BC; Reid JL Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164 [TBL] [Abstract][Full Text] [Related]
13. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine. Hamilton BP; Mersey JH; Hamilton J; Kuzbida G; Pavlis R; Levinson P Clin Pharmacol Ther; 1984 Nov; 36(5):628-33. PubMed ID: 6488684 [TBL] [Abstract][Full Text] [Related]
14. Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension. Pérez-Stable EJ; Coates TJ; Baron RB; Biró BS; Hauck WW; McHenry KS; Gardiner PS; Feigal D J Gen Intern Med; 1995 Aug; 10(8):419-28. PubMed ID: 7472698 [TBL] [Abstract][Full Text] [Related]
15. Clonidine and guanfacine in hypertension. Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307 [TBL] [Abstract][Full Text] [Related]
16. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension. Planz G; Beckenbauer U; Bundschu HD Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755 [TBL] [Abstract][Full Text] [Related]
17. Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Hansson L; Hunyor SN; Julius S; Hoobler SW Am Heart J; 1973 May; 85(5):605-10. PubMed ID: 4697628 [No Abstract] [Full Text] [Related]
18. Involvement of central noradrenergic mechanisms in the rebound hypertension following clonidine withdrawal. Augustine SJ; Buckley JP; Tachikawa S; Lokhandwala MF J Cardiovasc Pharmacol; 1982; 4(3):449-55. PubMed ID: 6177942 [TBL] [Abstract][Full Text] [Related]
19. Effects of clonidine withdrawal: possible mechanisms and suggestions for management. Hunyor SN; Hansson L; Harrison TS; Hoobler SW Br Med J; 1973 Apr; 2(5860):209-11. PubMed ID: 4700009 [TBL] [Abstract][Full Text] [Related]
20. Drug therapy: clonidine, a new antihypertensive drug. Pettinger WA N Engl J Med; 1975 Dec; 293(23):1179-80. PubMed ID: 1102978 [No Abstract] [Full Text] [Related] [Next] [New Search]